{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:48:16Z","timestamp":1767991696264,"version":"3.49.0"},"update-to":[{"DOI":"10.1016\/j.ymgme.2021.04.002","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000}}],"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ymgme.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T12:41:29Z","timestamp":1617799289000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["WITHDRAWN: Phenylalanine hydroxylase deficient phenylketonuria comparative metabolomics identifies energy pathway disruption and oxidative stress"],"prefix":"10.1016","author":[{"given":"Steven F.","family":"Dobrowolski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Leng","family":"Phua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cayla","family":"Sudano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Spridik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal O.","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivakama","family":"Bharathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Goetzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.04.002_bb0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3476(74)80124-1","article-title":"Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant","volume":"85","author":"MacCready","year":"1974","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-019-1188-0","article-title":"The cardiovascular phenotype of adult patients with phenylketonuria","volume":"14","author":"Azabdaftari","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13023-015-0232-y","article-title":"Bone health in phenylketonuria: a systematic review and meta-analysis","volume":"10","author":"Demirdas","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0030","doi-asserted-by":"crossref","first-page":"100649","DOI":"10.1016\/j.ymgmr.2020.100649","article-title":"Altered visual functions, macular ganglion cell and papillary retinal nerve fiber layer thickness in early-treated adult PKU patients","volume":"25","author":"Serfozo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0035","first-page":"514","article-title":"Phenylpyruvic oligophrenia: deficiency of phenylalanine oxidizing system","volume":"82","author":"Jervis","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","article-title":"International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria","volume":"127","author":"Muntau","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03007995.2018.1528215","article-title":"Pegvaliase: a novel treatment option for adults with phenylketonuria","volume":"35","author":"Mahan","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2021.04.002_bb0060","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","author":"de Groot","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.04.003","article-title":"Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: a longitudinal study","volume":"115","author":"Nardecchia","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2021.04.002_bb0070","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-8993(72)90653-1","article-title":"The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain","volume":"47","author":"McKean","year":"1972","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3476(81)80832-3","article-title":"Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia","volume":"98","author":"Butler","year":"1981","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10545-008-0946-2","article-title":"Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0095","doi-asserted-by":"crossref","first-page":"141523","DOI":"10.1172\/jci.insight.141523","article-title":"A porcine model of phenylketonuria generated by CRISPR\/Cas9 genome editing","volume":"15","author":"Koppes","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0100","first-page":"129832","article-title":"Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders","volume":"2020","author":"Ikawa","year":"1865","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2016.01.001","article-title":"DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria","volume":"119","author":"Dobrowolski","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1758-2946-2-9","article-title":"Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries","volume":"2","author":"Dehaven","year":"2010","journal-title":"J. Cheminform."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0125","series-title":"Metabolomics","first-page":"167","article-title":"Software techniques for enabling high-throughput analysis of metabolomic datasets","author":"DeHaven","year":"2012"},{"key":"10.1016\/j.ymgme.2021.04.002_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jchromb.2017.04.002","article-title":"Automated pathway and reaction prediction facilitates in silico identification of unknown metabolites in human cohort studies","volume":"1071","author":"Quell","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2020.01.005","article-title":"Clinical, biochemical, mitochondrial, and metabolomic aspects of methylmalonate semialdehyde dehydrogenase deficiency: report of a fifth case","volume":"129","author":"Dobrowolski","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0140","doi-asserted-by":"crossref","first-page":"10239","DOI":"10.1074\/jbc.M117.785022","article-title":"Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain","volume":"292","author":"Zhang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0145","doi-asserted-by":"crossref","first-page":"101253","DOI":"10.1016\/j.redox.2019.101253","article-title":"The fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase can be a source of mitochondrial hydrogen peroxide","volume":"26","author":"Zhang","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0150","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1039\/C4AY00288A","article-title":"Measurement of DCF fluorescence as a measure of reactive oxygen species in murine islets of Langerhans","volume":"6","author":"Wang","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ymgme.2021.04.002_bb0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1005694122277","article-title":"Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment","volume":"23","author":"Burlina","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11011-020-00550-1","article-title":"Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes","volume":"35","author":"Kirby","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0170","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/s41436-019-0442-0","article-title":"Members of the UCDC. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders","volume":"21","author":"Burrage","year":"2019","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bj1480085","article-title":"The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors","volume":"148","author":"Halestrap","year":"1975","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-4159.1973.tb12128.x","article-title":"Pyruvate metabolism by homogenates of human brain: effects of phenylpyruvate and implications for the etiology of the mental retardation in phenylketonuria","volume":"20","author":"Patel","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0185","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1073\/pnas.63.4.1365","article-title":"Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage","volume":"63","author":"Weber","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajcn\/28.2.183","article-title":"Phenylketonuria: metabolic alterations induced by phenylalanine and phenylpyruvate","volume":"28","author":"Patel","year":"1975","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0195","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1007\/s11033-019-05023-y","article-title":"Creatine nanoliposome reverts the HPA-induced damage in complex II-III activity of the rats\u2019 cerebral cortex","volume":"46","author":"Mezzomo","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0200","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s11011-019-00472-7","article-title":"Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria","volume":"34","author":"Bortoluzzi","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuint.2018.01.001","article-title":"Brain bioenergetics in rats with acute hyperphenylalaninemia","volume":"117","author":"Dimer","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0210","first-page":"6","article-title":"Evidence of oxidative stress and secondary mitochondrial dysfunction in metabolic and non-metabolic disorders","volume":"19","author":"Stepien","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1015529511664","article-title":"Inhibition of the mitochondrial respiratory chain by phenylalanine in rat cerebral cortex","volume":"27","author":"Rech","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0220","series-title":"Gene Reviews","article-title":"Very long-chain acyl-coenzyme A dehydrogenase deficiency","author":"Leslie","year":"1993"},{"key":"10.1016\/j.ymgme.2021.04.002_bb0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1026374114314","article-title":"Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals","volume":"17","author":"Boldyrev","year":"1997","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11011-006-9035-0","article-title":"Investigation of oxidative stress parameters in treated phenylketonuric patients","volume":"21","author":"Sitta","year":"2006","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0240","first-page":"68","article-title":"Oxidative stress in patients with phenylketonuria","volume":"2005","author":"Sirtori","year":"1740","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2021.04.002_bb0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.137.329","article-title":"Comparison of cytosolic and mitochondrial enzyme alterations in the livers of propionic or methylmalonic acidemia: a reduction of cytochrome oxidase activity","volume":"137","author":"Hayasaka","year":"1982","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0250","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/path.2248","article-title":"Methylmalonic acidaemia leads to increased production reactive oxygen species and induction of apoptosis through the mitocondrial\/caspase pathway","volume":"213","author":"Richard","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1651-2227.1968.tb07314.x","article-title":"Methylmalonic academia. A disorder associated with acidosis, hyperlycaemia, and hyperlactatemia","volume":"57","author":"Lindblad","year":"1968","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0260","doi-asserted-by":"crossref","first-page":"14674","DOI":"10.1074\/jbc.M200997200","article-title":"Neurodegeneration in Methylmalonic Aciduria involves inhibition of complex II and the Tricarboxylic acid cycle, and synergistically acting Excitotoxicity","volume":"277","author":"Okun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0014-4886(03)00113-4","article-title":"Ammonia potentiates methylmalonic acid-induced convulsions and TBARS production","volume":"182","author":"Marisco","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0270","doi-asserted-by":"crossref","first-page":"20998","DOI":"10.1016\/S0021-9258(18)54810-9","article-title":"Decreased activities of ubiqunol; ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c: oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[C-lactam]-induced methylmalonic aciduria","volume":"266","author":"Krahenbuhl","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijdevneu.2005.10.005","article-title":"Differential inhibitory effects of methylmalonic acid on respitratory chain complex activities in rat tissues","volume":"24","author":"Pettenuzzo","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0280","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1096\/fj.08-121848","article-title":"Mitochondrial dysfunction in Mut methylmalonic academia","volume":"23","author":"Chandler","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1203\/PDR.0b013e3181a7c270","article-title":"Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria","volume":"66","author":"De Keyzer","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-3476(96)70080-X","article-title":"Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate","volume":"129","author":"Treacy","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0295","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1073\/pnas.0813409106","article-title":"Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia","volume":"106","author":"Atkuri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0300","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","article-title":"Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy","volume":"22","author":"L\u00f3pez-Erauskin","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0305","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118182","article-title":"Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy","volume":"96","author":"Ho","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S0317167100044863","article-title":"Mitochondrial myopathy of cerebrohepato-renal (Zellweger) syndrome","volume":"10","author":"Sarnat","year":"1983","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0315","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s10571-012-9834-2","article-title":"Phenylpyruvic acid decreases glucose-6-phosphate dehydrogenase activity in rat brain","volume":"32","author":"Rosa","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0005-2736(74)90140-0","article-title":"Inhibition of mitochondrial pyruvate transport by phenylpyruvate and alpha-ketoisocaproate","volume":"367","author":"Halestrap","year":"1974","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2021.04.002_bb0325","first-page":"85","article-title":"Inhibition of pyruvate oxidation by skeletal muscle mitochondria by phenylpyruvate","volume":"23","author":"Swierczy\u0144ski","year":"1976","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0330","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2015.04.002","article-title":"Altered DNA methylation in PAH deficient phenylketonuria","volume":"115","author":"Dobrowolski","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0335","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/epi.14.84","article-title":"Oxidative stress and DNA methylation regulation in the metabolic syndrome","volume":"7","author":"Yara","year":"2015","journal-title":"Epigenomics."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0340","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2217\/epi-2016-0002","article-title":"Oxidative stress signaling to chromatin in health and disease","volume":"8","author":"Kreuz","year":"2016","journal-title":"Epigenomics."},{"key":"10.1016\/j.ymgme.2021.04.002_bb0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2015.01.028","article-title":"Oxidative stress alters global histone modification and DNA methylation","volume":"82","author":"Niu","year":"2015","journal-title":"Free Radic. Biol. Med."}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2021.04.002","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221006867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221006867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:23:45Z","timestamp":1761056625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221006867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":66,"alternative-id":["S1096719221006867"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.04.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WITHDRAWN: Phenylalanine hydroxylase deficient phenylketonuria comparative metabolomics identifies energy pathway disruption and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}